For Immediate Release Ancillary Care Management Announces Name Change to NovoLogixSM Minneapolis, MN (September 10, 2008)—Ancillary Care Management (ACM), a leading healthcare technology company, today announced that it has changed its corporate name to NovoLogix. The change is effective immediately. “Building on the company’s rich history and our 13-year track record servicing healthcare clients across the country, our new name captures the essence of the technology-driven processes and fresh thinking that have been the hallmarks of our success,” said David J. McLean, NovoLogix CEO. From Latin, Novo means ‘new, innovation’; Logix (or Logos) is taken from Greek, meaning ‘intelligent, smart, logic’. Commenting on the reasons behind the change, McLean added, “Healthcare has evolved dramatically over the past decade, particularly in the home health/ancillary care field: changing economic demands and government mandates, the flood of biopharmaceuticals in the market, shifting sites of care, and the administration support required for many of the new drug therapies. As a company, we have done much more than keep pace with the changes. We have helped our clients stay ahead of the curve. Now, given where we are in the industry and where we are as a business, the time is right for us to rename and rebrand the company in a way that more accurately reflects the value and benefits we provide to clients. The field has grown and needs have changed, and there is more and more demand for our services and expertise outside of the ancillary space. We feel confident that the name and brand image of NovoLogix translates our vision for the future into one clear message, while also acknowledging the core competencies and capabilities that helped us get to where we are today.” Along with the name change, the company has adopted a new logo and branding, and has unveiled a new web site at www.novologix.net. New provider and client sites are under development. And a marketing campaign via print, trade shows, and online media is planned to promote the NovoLogixSM brand throughout 2008. The company also recently announced a new business development initiative focused on meeting the unique needs of federal- and state-level government programs (e.g., Medicare and Medicaid) for value-driven electronic technology services to manage and re-price pharmaceuticals paid under the medical benefit. NovoLogix remains committed to providing current customers with the latest technology and services to manage trend, maximize revenue, reduce costs, and eliminate administrative inefficiencies, and will continue to reach out to other commercial clients as well, including national health plans, pharmacy benefits management companies (PBMs), and pharmacy and device manufacturers. “Our new name and new initiatives will drive our focus on the future and the ways that we can help our clients exploit both existing and emerging technologies to fundamentally change the economics of America’s healthcare system and keep us all moving forward,” McLean concluded. Company History Beginning in 1995, co-founders Dave Willcutts and Tom McNulty built an organization committed to providing an informational infrastructure for managing and integrating all the varied and distinct facets of what was then the infancy of home care. A pioneer throughout the industry’s developing years as Ancillary Care Management, the company created new technology-driven logic and protocols for processing prior authorizations and a proprietary NDC to HCPCS Crosswalk Methodology that accurately and precisely prices claims—in particular drugs, injectables, infusibles, and other pharmaceuticals paid under the medical benefit. These two state-of-the-art technology applications serve as the foundation for the new NovoLogix —a company that will drive healthcare innovation for decades to come. NovoLogix Today NovoLogix delivers technology applications, systems, and processes to positively impact both the economics and quality of how services and drugs are priced, paid for, and delivered to patients across the U.S. Next generation innovations include value-driven electronic technology to manage and re-price claims—in particular drugs, injectables, infusibles, and other pharmaceuticals paid under the medical benefit—decision support tools to manage prior authorizations, and nationally-recognized patient care programs. Covering millions of members for the nation’s largest health plans, pharmacy benefits management companies (PBMs), and other payers, Minneapolis-based NovoLogix is URAC-accredited and holds full accreditation by EHNAC. www.novologix.net Return to News & Events | Return Home